Conference Highlights
- PDF / 143,973 Bytes
- 8 Pages / 612.28 x 790.87 pts Page_size
- 90 Downloads / 191 Views
NEWS
ª 2010 Adis Data Information BV. All rights reserved.
Conference Highlightsy
Contents 1. American Society of Clinical Oncology (ASCO): 46th Annual Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251 1.1 Genetic Markers Predict Susceptibility to Chemotherapy-Induced Toxicities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251 1.2 Cost and Outcomes of Genetic Testing and Treatment in Breast Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252 2. Society of Gynecological Oncologists (SGO): 41st Annual Meeting on Women’s Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254 2.1 The Economic Burden of the Revolving Door . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254 2.2 The Economic Burden of Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254 2.3 The Economic Burden of Inappropriate Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254 3. International Society for Pharmacoeconomics and Outcomes Research (ISPOR): 15th Annual International Meeting . . . . . . . . . . 255 3.1 Genetic Testing Plus Donepezil May Be Cost Effective for Preventing Alzheimer’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255 4. American Urological Association: 105th Annual Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255 4.1 Cost Effectiveness of Finasteride: A Risky Business?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255 5. 17th Conference on Retroviruses and Opportunistic Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255 5.1 Universal Acute HIV Screening in the US. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255 6. European League Against Rheumatism (EULAR): 11th Annual Congress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256 6.1 Genetic Testing May Minimize Liver Injury Risk for Lumiracoxib . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256 7. European Haematology Association: 15th Congress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256 7.1 Testing for NT-proBNP Levels Can Predict the Risk of Major Chemotherapy-Related Toxicity and Death . . . . . . . . . . . . . . . . . . 256 8. American College of Cardiology: 59th Annual Scie
Data Loading...
